Galen Growth Asia ranks Nova Satra Dx first in Asia according to their HealthTech Alpha Score

Galen Growth Asia’s newly launched HealthTech Alpha Analytics platform, showcases 10 Asia-based ventures which use Liquid Biopsy as their main technology to provide their services and ranked Nova Satra Dx No.1 according to their HealthTech Alpha Score.

For more information please go to:

Liquid Biopsy: 10 Next Generation Startups in Asia